Skip to content

Prodrug of tenofovir works well in the presence of some NRTI resistance

First case of potential PI cross-resistance reported after lopinavir failure

Boosted PIs superior to no PIs as salvage therapy in highly PI-experienced

2NN study full results: nevirapine inferior to efavirenz?

Four year follow-up shows Kaletra to be safe, effective, durable

Resistant HIV strains persist after at least five years on suppressive HAART

HIV envelope may hold clues to likely treatment response

Variations in the P-gp gene do not affect disease progression rates

Transmission of drug-resistant HIV: what are the implications for treatment?